Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Treasury Shares (2016 - 2025)

Anaptysbio's Treasury Shares history spans 5 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 11.85% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 11.85%, while the annual FY2025 figure was $1.4 million, 11.85% up from the prior year.
  • Treasury Shares reached $1.4 million in Q4 2025 per ANAB's latest filing, up from $490228.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.6 million in Q2 2025 to a low of $292898.0 in Q1 2025.
  • Average Treasury Shares over 4 years is $1.4 million, with a median of $1.3 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: skyrocketed 297.21% in 2024, then plummeted 86.21% in 2025.
  • A 4-year view of Treasury Shares shows it stood at $1.0 million in 2022, then skyrocketed by 106.47% to $2.1 million in 2023, then tumbled by 42.21% to $1.2 million in 2024, then rose by 11.85% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Treasury Shares are $1.4 million (Q4 2025), $490228.0 (Q3 2025), and $2.6 million (Q2 2025).